Table 3.
Evaluation of hemodynamic and echocardiogram parameter on the 1st and 7th days of TTN and control groups.
| Parameter* | TTN (n = 15) | Control (n = 15) | P | |||||
|---|---|---|---|---|---|---|---|---|
| 1st daya | 7th dayb | 1st dayc | 7th dayd | a versus b | c versus d | a versus c | b versus d | |
| CO (mL/minute) | 332.0 ± 34.5 (256–398) |
312.8 ± 25.8 (277–345) |
302.4 ± 24.9 (245–345) |
301.2 ± 22.3 (256–334) |
<0.01 | >0.05 | <0.05 | >0.05 |
| EF (%) | 51.1 ± 1.0 (48–55) |
49.0 ± 1.0 (47–53) |
49.0 ± 2.0 (47–55) |
43.0 ± 3.0 (43–54) |
<0.01 | <0.05 | <0.05 | >0.05 |
| LVEDD (mm/kg) | 30.76 ± 1.63 (28.0–33.2) |
29.44 ± 1.05 (27.6–31.2) |
29.73 ± 1.18 (28.0–33.0) |
29.38 ± 0.79 (28.4–31.8) |
<0.01 | >0.05 | <0.05 | >0.05 |
| LVESD (mm/kg) | 14.66 ± 1.32 (12.9–17.6) |
12.92 ± 1.23 (10.7–14.5) |
12.18 ± 0.82 (10.7–13.1) |
11.89 ± 0.72 (10.5–12.8) |
<0.001 | >0.05 | <0.001 | <0.01 |
| RVEDD (mm/kg) | 24.26 ± 2.25 (21.2–27.5) |
23.66 ± 2.72 (19.5–27.4) |
21.34 ± 2.0 (18.8–24.5) |
20.88 ± 1.47 (18.7–24.2) |
<0.05 | >0.05 | <0.01 | <0.01 |
| RVESD (mm/kg) | 11.13 ± 0.92 (10.2–13.0) |
10.18 ± 0.84 (8.5–11.3) |
10.34 ± 1.01 (8.0–12.1) |
9.78 ± 1.26 (8.0–12.0) |
<0.05 | >0.05 | <0.05 | >0.05 |
| LA/Aorta | 1.43 ± 0.12 (1.21–1.68) |
1.15 ± 0.08 (0.99–1.26) |
1.12 ± 0.09 (1.0–1.30) |
1.12 ± 0.08 (1.0–1.30) |
<0.001 | >0.05 | <0.001 | >0.05 |
| FS (%) | 30.26 ± 2.05 (27.0–34.0) |
30.20 ± 2.23 (27.0–35.0) |
31.0 ± 2.1 (28.0–35.0) |
30.6 ± 1.8 (28.0–34.0) |
>0.05 | >0.05 | >0.05 | >0.05 |
| HR (/minute) | 159.6 ± 7.21 (148–172) |
146.33 ± 8.55 (133–165) |
144.0 ± 10.8 (118–156) |
138.7 ± 12.0 (110–153) |
<0.001 | >0.05 | <0.001 | >0.05 |
| mBP (mmHg) | 52.7 ± 6.05 (44–65) |
49.5 ± 6.6 (40–64) |
46.3 ± 5.03 (40–57) |
49.4 ± 5.5 (41–59) |
>0.05 | >0.05 | <0.01 | >0.05 |
*Values are represented as mean ± SD (min.–max.).